Risk of adverse events among older adults following co-prescription of clarithromycin and statins notmetabolized by cytochrome P450 3A4.

 Among older adults taking a statin not metabolized by CYP3A4 (rosuvastatin/pravastatin/fluvastatin), co-prescription of clarithromycin versus azithromycin was associated with a modest but statistically significant increase in the 30-day absolute risk of adverse outcomes, including AKI and admission with hyperkalemia. : Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report Novartis announces termination of ALTITUDE study Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
Source: Nephrology Now - Category: Urology & Nephrology Authors: Tags: Acute Kidney Injury Internal Medicine for Nephrologists Source Type: research